DiaSorin Molecular Covid-19 Test Receives Emergency Use Authorization
The test is highly specific to covid-19 and targets several regions of the viral genome to minimize the impact on performance should there be possible future mutations.
Read MorePosted by Steve Halasey | Mar 24, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The test is highly specific to covid-19 and targets several regions of the viral genome to minimize the impact on performance should there be possible future mutations.
Read MorePosted by | Mar 24, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
If authorized, the new tests would increase the potential capacity to screen for covid-19 by thousands of tests per day.
Read MorePosted by | Mar 24, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The virus was detectable for up to 3 hours in aerosols, up to 4 hours on copper, up to 24 hours on cardboard, and up to 3 days on plastic and stainless steel.
Read MorePosted by | Mar 24, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Section 1135 authority includes the ability to grant state and territorial Medicaid agencies a wider range of flexibilities. States may now submit Section 1135 waiver requests that will remove administrative burdens and expand access to needed services.
Read MorePosted by | Mar 24, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
FDA has issued emergency use authorizations to Hologic for its Panther Fusion SARS-CoV-2 assay and to LabCorp for its Covid-19 RT-PCR test.
Read More